These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 553082)
21. Relative importance of bacterial and mammalian nitroreductases for niridazole mutagenesis. Blumer JL; Friedman A; Meyer LW; Fairchild E; Webster LT; Speck WT Cancer Res; 1980 Dec; 40(12):4599-605. PubMed ID: 6893679 [TBL] [Abstract][Full Text] [Related]
22. Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells. Chattopadhyay S; O'Rourke J; Cone RE Int Immunol; 2008 Apr; 20(4):509-16. PubMed ID: 18359787 [TBL] [Abstract][Full Text] [Related]
23. Effects on murine trichinosis of niridazole, a suppressant of cellular but not humoral immunological responses. Grove DI; Warren KS Ann Trop Med Parasitol; 1976 Dec; 70(4):449-53. PubMed ID: 999358 [TBL] [Abstract][Full Text] [Related]
24. Two stages in lymphocyte mediator production by differential susceptibility to blockade using niridazole. Daniels JC; Fajardo I; David JR Proc Natl Acad Sci U S A; 1975 Nov; 72(11):4569-72. PubMed ID: 1105584 [TBL] [Abstract][Full Text] [Related]
25. Biphasic response for hepatic microsomal enzyme induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice. Shen ES; Guengerich FP; Olson JR Biochem Pharmacol; 1989 Nov; 38(22):4075-84. PubMed ID: 2512931 [TBL] [Abstract][Full Text] [Related]
26. Reductive metabolism of niridazole by adult Schistosoma mansoni. Correlation with covalent drug binding to parasite macromolecules. Tracy JW; Catto BA; Webster LT Mol Pharmacol; 1983 Sep; 24(2):291-9. PubMed ID: 6193406 [TBL] [Abstract][Full Text] [Related]
27. Biochemical effects of niridazole. I. In vitro and in vivo effect of niridazole on the rate of gluconeogenesis and oxidation of pyruvate and some Krebs cycle intermediates in mice. Sharaf AA; Khayyal MT; Kheir-el-Din A; Sharaf AA; Kassem F Egypt J Bilharz; 1978; 5(1-2):49-57. PubMed ID: 555754 [TBL] [Abstract][Full Text] [Related]
28. Alteration of methylcholanthrene-mediated suppression of cutaneous delayed hypersensitivity by benzoflavone treatment of C57BL/6J mice. Frank DM; Blumer JL Toxicol Appl Pharmacol; 1988 Aug; 95(1):72-81. PubMed ID: 2842891 [TBL] [Abstract][Full Text] [Related]
29. Effect of oral niridazole treatment on some bacterial infections in mice. Collins FM Antimicrob Agents Chemother; 1975 Apr; 7(4):453-6. PubMed ID: 125067 [TBL] [Abstract][Full Text] [Related]
30. In vivo function tests of the effect of tilorone and niridazole on cell-mediated immunity in chickens. Donahoe JP; Giambrone J; Fletcher OJ; Kleven SH Am J Vet Res; 1977 Dec; 38(12):2013-7. PubMed ID: 23063 [TBL] [Abstract][Full Text] [Related]
31. Identification and purification of immunosuppressive activity in the urine of rats and a human patient treated with niridazole. Lucas SV; Daniels JC; Schubert RD; Simpson JM; Mahmoud AA; warren KS; David JR; Webster LT J Immunol; 1977 Feb; 118(2):418-22. PubMed ID: 320258 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of human mixed lymphocyte reactions by sera and urine dialysates from niridazole-treated rats. Jones BM; Bird M; Howells M; Massey PR; Millar D; Miller JJ; Reeves S; Salaman JR Transplantation; 1977 Aug; 24(2):134-140. PubMed ID: 143090 [No Abstract] [Full Text] [Related]
33. Niridazole metabolism by rat embryos in vitro. Fantel AG; Person RE; Tracy JW; Juchau MR Teratology; 1988 Mar; 37(3):213-21. PubMed ID: 3368875 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of niridazole as a suppressant of cellular immunity in chickens. Walser MM Am J Vet Res; 1978 Nov; 39(11):1858-60. PubMed ID: 736345 [TBL] [Abstract][Full Text] [Related]
35. Biochemical effects of niridazole. II. In vitro and in vivo effects of niridazole on the rate of gluconeogenesis and the rate of oxidation of pyruvate and some Krebs cycle intermediates in Schistosoma mansoni infected mice. Sharaf AA; Khayyal MT; Kheir-el-Din A; Sharaf AA; Kassem F Egypt J Bilharz; 1978; 5(1-2):59-69. PubMed ID: 555755 [TBL] [Abstract][Full Text] [Related]
36. Mutagenic effects of niridazole in animal-mediated and in liquid suspension assays using Escherichia coli K-12 as an indicator. Knasmüller S; Szakmary A Mutat Res; 1992 Aug; 280(2):93-101. PubMed ID: 1378543 [TBL] [Abstract][Full Text] [Related]
37. Coexpression of Ah receptor and CYP1A1 in hepatocytes of C57BL/6J and DBA/2J mice. Forkert PG Toxicol Appl Pharmacol; 1997 Jan; 142(1):69-78. PubMed ID: 9007035 [TBL] [Abstract][Full Text] [Related]
38. An investigation of the immunosuppressive effects of niridazole and metronidazole in rat and baboon heterotopic cardiac allograft models. Boyd ST; Cooper DK; Baigrie R; Rose AG; Barnard CN Transplantation; 1981 May; 31(5):326-9. PubMed ID: 7015621 [TBL] [Abstract][Full Text] [Related]
39. 1-thiocarbamoyl-2-imidazolidinone, a metabolite of niridazole in Schistosoma mansoni. Catto BA; Tracy JW; Webster LT Mol Biochem Parasitol; 1984 Jan; 10(1):111-20. PubMed ID: 6546409 [TBL] [Abstract][Full Text] [Related]